Skip to main content

Table 10 Patient characteristics focusing on structural CMR results

From: Identification of cardiomyopathy associated circulating miRNA biomarkers in patients with muscular dystrophy using a complementary cardiovascular magnetic resonance and plasma profiling approach

  MD LGE-negative LGE-positive p value
N = 63 N = 15 N = 48
Male, n (%) 63 (100) 15 (100) 48 (100) 1.00
Age, years 31 ± 15 25 ± 17 32 ± 14 0.13
BMD, n (%) 51 (81) 14 (93) 37 (77) 0.26
BMI, kg/m2 24 ± 4 23 ± 5 24 ± 4 0.38
Skeletal muscle status 0/1/2/3, n (%) 2 (3)/43 (68)/13 (21)/5 (8) 2 (13)/11 (73)/1 (7)/1 (7) 32 (67)/12 (25)/4 (8)/0 (0) 0.06
ACE inhibitor, n (%) 16 (25) 1 (7) 15 (31) 0.09
Beta-blocker, n (%) 14 (22) 1 (7) 13 (27) 0.16
CK, U/L 1226 (653–2424) 773 (607–2187) 1358 (797-2481) 0.18
Elevated hs-trop, n (%)a 30 (48) 2 (13) 28 (58) 0.003
Elevated NT-proBNP, n (%)b 3 (5) 0 (0) 3 (6) 1.00
  1. a > 14 pg/mL; b > 450 pg/mL
  2. Bold text indicates a significant p-value of <0.05